SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-22-023917
Filing Date
2022-12-15
Accepted
2022-12-15 10:46:22
Documents
11
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6236
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 600304
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 183496
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 6069
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 6182
6 GRAPHIC exhibit99-1x001.jpg GRAPHIC 9304
7 GRAPHIC exhibit99-1xu001.jpg GRAPHIC 975
8 GRAPHIC exhibit99-1xu002.jpg GRAPHIC 1457
9 GRAPHIC exhibit99-2x001.jpg GRAPHIC 9304
10 GRAPHIC exhibit99-2xu002.jpg GRAPHIC 1457
11 GRAPHIC exhibit99-2xu003.jpg GRAPHIC 1020
  Complete submission text file 0001062993-22-023917.txt   836848
Mailing Address SUITE 820, 1075 WEST GEORGIA STREET VANCOUVER A1 V6E 3N9
Business Address SUITE 820, 1075 WEST GEORGIA STREET VANCOUVER A1 V6E 3N9 604-336-8613
C21 Investments Inc. (Filer) CIK: 0000831609 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 000-55982 | Film No.: 221463987
SIC: 2833 Medicinal Chemicals & Botanical Products